Surrozen
$0.02
12
+$0+1.06% Friday 19:55
Statistics
Day High
0.02
Day Low
0.02
52W High
0.02
52W Low
0.02
Volume
2,992
Avg. Volume
-
Mkt Cap
163,706.1
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
13MayExpected
Expected EPS
-1.0525
Actual EPS
N/A
Financials
-596.56%Profit Margin
Unprofitable21.31MRevenue
-127.13MNet Income
Analyst Ratings
38Average Price Target
The highest estimate is 40.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SRZNW. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.17B
Vertex Pharmaceuticals
VRTX
Mkt Cap110.97B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.49B
Alnylam Pharmaceuticals
ALNY
Mkt Cap42.72B
CRISPR Therapeutics
CRSP
Mkt Cap4.92B
Novartis
NVS
Mkt Cap297.35B
Pfizer
PFE
Mkt Cap153.13B
Gilead Sciences
GILD
Mkt Cap172.51B
About
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body's existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 that stimulates hepatocyte regeneration, improves liver function, and reduces fibrosis; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are highly expressed in intestinal crypts. The company was founded in 2016 and is headquartered in South San Francisco, California.
Show more...
CEO
Mr. Craig C. Parker M.B.A.
Employees
40
Country
United States
ISIN
US86889P1176
Listings
0 Comments
Share your thoughts
FAQ
What is Surrozen stock price today?▼
The current price of SRZNW is $0.02 USD — it has increased by +1.06% in the past 24 hours. Watch Surrozen stock price performance more closely on the chart.
What is Surrozen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Surrozen stocks are traded under the ticker SRZNW.
What is Surrozen market cap?▼
Today Surrozen has the market capitalization of 163,706.1
When is the next Surrozen earnings date?▼
Surrozen is going to release the next earnings report on May 13, 2026.
What were Surrozen earnings last quarter?▼
SRZNW earnings for the last quarter are -19.13 USD per share, whereas the estimation was -1.29 USD resulting in a -1,385.83% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Surrozen revenue for the last year?▼
Surrozen revenue for the last year amounts to 21.31M USD.
What is Surrozen net income for the last year?▼
SRZNW net income for the last year is -127.13M USD.
How many employees does Surrozen have?▼
As of April 19, 2026, the company has 40 employees.
In which sector is Surrozen located?▼
Surrozen operates in the Health & Wellness sector.
When did Surrozen complete a stock split?▼
The last stock split for Surrozen was on December 14, 2023 with a ratio of 1:15.
Where is Surrozen headquartered?▼
Surrozen is headquartered in South San Francisco, United States.